The mitochondria-targeted hydrogen sulfide donor AP39 improves health and mitochondrial function in a C. elegans primary mitochondrial disease model. (2021)
Attributed to:
External Collaboration, Innovation and Entrepreneurism: Translational Medicine in Exeter
(EXCITEME)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/jimd.12345
PubMed Identifier: 33325042
Publication URI: http://europepmc.org/abstract/MED/33325042
Type: Journal Article/Review
Volume: 44
Parent Publication: Journal of inherited metabolic disease
Issue: 2
ISSN: 0141-8955